UPdates

BITOPERTIN CLINICAL TRIALS- UPDATE 

Join Dr. Amy Dickey to learn more about the the analysis of phase 2 clinical trials testing the safety and effectiveness of bitopertin to treat EPP.

Date: Saturday, July 13, 2024
Time: Noon ET
Location: Zoom

REGISTER TO RECEIVE THE LINK

 


PHASE 3 INSPIRE STUDY FOR MT-7117 NOW RECRUITING PARTICIPANTS
Eligible participants must have EPP or XLP diagnosis, have not previously received MT-7117, be age 12+ and meet additional eligibility requirements. Please complete an INTEREST FORM. Your response is completely confidential, only for designating your interest in further information. Contact UPA at 800-868-1292 or email us at info@porphyria.org with any questions.
 

PHASE 2 AURORA TRIAL FOR BITOPERTIN TO TREAT EPP IS NOW FULLY ENROLLED!
Thank you to Disc Medicine, all the patients, supportive family and friends, researchers and study coordinators who have made this trial possible.

 

MT-7117 PHASE 3 TRIAL CONTINUES ACCESS TO DERSIMELAGON AT 200MG DOSE

 

Patients who completed the Phase 3 clinical trial and are currently participating in the Open Label Extension (OLE) will now have continued access to dersimelagon.

  • Who is eligible? Patients who completed the Phase 3 clinical trial
  • Extension time period: Participants will have access to up to an additional 36 weeks
  • Action: Contact your Study Site to transition to this dose at your next regular study visit.


PRELIMINARY FINDINGS RELEASED FOR BITOPERTIN
Disc Medicine recently shared preliminary findings from its ongoing, Phase 2 open-label BEACON trial in Australia which is evaluating bitopertin in patients with EPP and XLP. Early results found:

  • Bitopertin consistently decreases protoporphyrin IX
  • Patients had significant increases in reported sunlight tolerance and quality of life
  • Bitopertin was well-tolerated with no serious adverse events, no reported discontinuations or dose reductions, no adverse events greater than Grade 1 (mild), and no meaningful changes in observed in mean hemoglobin level

These data were presented at the European Hematology Association 2023 Congress in Frankfurt, Germany. More details about the results are available HERE.

UP and Coming

YOU ARE NOT ALONE!Connecting with others who understand what you're going through is a great way to build a support system and community. Join a Connect Up group to connect and socialize with others in a safe and inclusive environment. Next meetings:

  • Acute Hepatic Porphyrias (AIP, HCP & VP): July 15 at 7:00 pm ET
  • Acute Hepatic Porphyrias (AIP, HCP & VP): July 27 at noon ET

Additional groups for EPP, HCP/VP, CEP patients, and EPP caregivers are available! New groups are formed based on interests and experiences.

SIGN UP TO JOIN.

 

PRESENTATION & DISCUSSION: NUTRITION AND LIFESTYLE

Join us on Saturday, July 20 to learn about lifestyle and nutrition strategies to help you manage your porphyria.

We're excited to welcome with nutritionist and AIP patient Isabel Palazon to discuss this important topic!

Date: Saturday, July 20
Session 1 (en español): Noon-1:00 PM ET
Session 2 (in English): 1:30-2:30 PM ET

REGISTER TO RECEIVE THE LINK

 

 

 

PORPHYRIAPALOOZA 2024: FIRST EVER PORPHYRIA PATIENT AND FAMILY WEEKEND

Porphyria is hard enough… let’s get together to share stories, build community, and have fun!

Join us for PorphyriaPalooza, September 13-15, 2024 in Chicago, IL. The event is free and travel assistance is available.

LEARN MORE AND REGISTER



 

PORPHYRIA TOGETHER ON FACEBOOKWe welcome you to join Porphyria Together, a new closed Facebook group where you will find helpful information in a safe community setting. JOIN US

Resources for

Patients

Explore

Resources for

Physicians

Explore

Types of Porphyria

Types Icon

Acute Intermittent Porphyria (AIP)

Learn More.

Types Icon

Hereditary Coproporphyria (HCP)

Learn More.

Types Icon

Variegate Porphyria (VP)

Learn More.

Types Icon

ALAD-Deficiency Porphyria (ADP)

Learn More.

Types Icon

Porphyria Cutanea Tarda (PCT)

Learn More.

Types Icon

Erythropoietic Protoporphyria (EPP) and X-Linked Porphyria (XLP)

Learn More.

Types Icon

Congenital Erythropoietic Porphyria (CEP)

Learn More.

Types Icon

Hepatoerythro­poietic Porphyria (HEP)

Learn More.

Who we are

Our Mission

The United Porphyrias Association is committed to improving the quality of life of the porphyria patient community and is relentlessly focused on advancing disease awareness, research, and therapies in all the porphyrias.

Our Vision

A world where patients are free from the pain and challenges of porphyria.

More About Us

Member Highlight

Victor Mejias

Erythropoietic Protoporphyria (EPP)

"I was diagnosed at the age of 6 with EPP after my parents noticed that every time I was outside I was experiencing anguishing discomfort. I never fully comprehended my diagnosis until I was able to connect with others. With the help of the UPA, I want to be able to help others live more comfortably with EPP and support the vision of a world where patients are free from the pain and challenges of porphyria. "

Member Highlight image

Proud Partners in Porphyria Advocacy

Consortium
Apex image
CSD image
Epnet image
Global Genes image
GPAC image
Haystack image
Global Skin image
Nord image
PatientWorthy image
PatientWorthy image
Rare Diseases image
Rare Diseases International image
Rare Diseases image

Join United Porphyrias

Join Now!